US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Precigen

4.16

-0.1100-2.58%

Post-market: 4.11-0.0500-1.20%19:41 EDT

Volume:2.83M

Turnover:11.82M

Market Cap:1.47B

PE:-3.03

High:4.37

Open:4.30

Low:4.07

Close:4.27

52wk High:5.47

52wk Low:1.23

Shares:353.82M

Float Shares:205.00M

Volume Ratio:0.70

T/O Rate:1.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3727

EPS(LYR):-1.3727

ROE:-571.97%

ROA:-44.30%

PB:70.39

PE(LYR):-3.03

Loading ...

Overview Company News Filings

AquaBounty Technologies Inc. Files Initial Beneficial Ownership Statement for Director Braeden Lichti

Precigen Inc. to Report Third Quarter 2025 Financial Results

Will Papzimeos FDA Approval and Major Buy Shift Precigen's (PGEN) Investment Narrative?

Simply Wall St.

AquaBounty Technologies Secures $4 Million in Senior Notes Financing at 18% Interest

AquaBounty Technologies Reports $1.4 Million Net Loss for Q3 2025

A Look at Precigen's (PGEN) Valuation Following FDA Approval of PAPZIMEOS

Simply Wall St.

Precigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer

A Look at Precigen (PGEN) Valuation After PAPZIMEOS’ Full FDA Approval and Clinical Breakthroughs

Simply Wall St.

BUZZ-U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv

Sector Update: Health Care Stocks Higher Premarket Monday

MT Newswires Live

Precigen Shares Rise on Positive Long-Term Follow-Up Data From Papzimeos

BUZZ-Precigen rises on long-term data of rare respiratory disease therapy

BRIEF-Precigen Reports Durable Responses With Papzimeos in Recurrent Respiratory Papillomatosis

Precigen’s PAPZIMEOS Receives Full FDA Approval as First Therapy for Adults with Recurrent Respiratory Papillomatosis

Precigen Inc - Surgery Reduction Observed in 95% of Patients by Year 3

THOMSON REUTERS

Precigen Inc - 83% of Responders Show Continued Complete Response After 36 Months

THOMSON REUTERS

Precigen Inc - No New Safety Events Observed During Long-Term Follow-up

THOMSON REUTERS

Precigen Announces Long-Term Follow-up Results Highlighting Ongoing Durable Complete Responses After Treatment With Papzimeos, the First and Only FDA-Approved Therapy for Adults With Recurrent Respiratory Papillomatosis

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PGEN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PGEN\",,,,,undefined,":{"symbol":"PGEN","market":"US","secType":"STK","nameCN":"Precigen","latestPrice":4.16,"timestamp":1775851200000,"preClose":4.27,"halted":0,"volume":2826565,"hourTrading":{"tag":"盘后","latestPrice":4.11,"preClose":4.16,"latestTime":"19:41 EDT","volume":31231,"amount":129789.2918,"timestamp":1775864519839,"change":-0.05,"changeRate":-0.012019,"amplitude":0.022163},"delay":0,"changeRate":-0.02576112412177973,"floatShares":204999999,"shares":353824499,"eps":-1.372743,"marketStatus":"Market Closed","change":-0.11,"latestTime":"04-10 16:00:00 EDT","open":4.3,"high":4.37,"low":4.07,"amount":11819501.1716005,"amplitude":0.070258,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.372743,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776067200000},"marketStatusCode":7,"adr":0,"listingDate":1375934400000,"exchange":"NASDAQ","adjPreClose":4.27,"preHourTrading":{"tag":"盘前","latestPrice":4.25,"preClose":4.27,"latestTime":"09:10 EDT","volume":462,"amount":1945.837971,"timestamp":1775826629644,"change":-0.02,"changeRate":-0.004684,"amplitude":0.035129},"postHourTrading":{"tag":"盘后","latestPrice":4.11,"preClose":4.16,"latestTime":"19:41 EDT","volume":31231,"amount":129789.2918,"timestamp":1775864519839,"change":-0.05,"changeRate":-0.012019,"amplitude":0.022163},"volumeRatio":0.7049318107504423,"impliedVol":0.8677,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PGEN\",,,,,undefined,":{"symbol":"PGEN","floatShares":204999999,"roa":"-44.30%","roe":"-571.97%","lyrEps":-1.372743,"volumeRatio":0.7049318107504423,"shares":353824499,"dividePrice":0,"high":4.37,"amplitude":0.070258,"preClose":4.27,"low":4.07,"week52Low":1.225,"pbRate":"70.39","psRate":"151.99","week52High":5.465,"institutionHeld":0,"latestPrice":4.16,"eps":-1.372743,"divideRate":0,"volume":2826565,"delay":0,"ttmEps":-1.372743,"open":4.3,"prevYearClose":4.18,"prevWeekClose":3.94,"prevMonthClose":3.87,"prevQuarterClose":3.87,"fiveDayClose":3.94,"twentyDayClose":3.28,"sixtyDayClose":4.17,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.005149301587301588},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-25","symbol":"PGEN","fiscalQuarterEnding":"2025/12","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2025-11-13","symbol":"PGEN","fiscalQuarterEnding":"2025/09","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-08-12","symbol":"PGEN","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-05-14","symbol":"PGEN","fiscalQuarterEnding":"2025/03","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-03-19","symbol":"PGEN","fiscalQuarterEnding":"2024/12","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":-0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PGEN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1755316800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PGEN","date":"2026-04-10","current":-3.030429,"percent":0.242938,"low":-11.918404,"twenty":-7.024617,"median":-3.735254,"eighty":-1.59508,"high":21.338289,"avg":-1.618188,"sd":7.894573,"marketCap":1511275429},"quantilePoints":[{"date":"2021-04-16","current":-9.033507,"twenty":-41.510553,"median":-9.298844,"eighty":-2.265217,"marketCap":1540402680},{"date":"2021-04-23","current":-9.733031,"twenty":-35.844723,"median":-9.248987,"eighty":-2.265217,"marketCap":1659686198},{"date":"2021-04-30","current":-9.363148,"twenty":-35.844723,"median":-9.248987,"eighty":-2.265217,"marketCap":1596613334},{"date":"2021-05-07","current":-7.916611,"twenty":-35.631226,"median":-9.089061,"eighty":-2.265217,"marketCap":1349948442},{"date":"2021-05-14","current":-10.834155,"twenty":-20.896671,"median":-9.089061,"eighty":-2.265217,"marketCap":1428385814},{"date":"2021-05-21","current":-10.646279,"twenty":-20.23822,"median":-9.089061,"eighty":-2.265217,"marketCap":1403616118},{"date":"2021-05-28","current":-10.333154,"twenty":-19.972391,"median":-9.089061,"eighty":-2.265217,"marketCap":1362333291},{"date":"2021-06-04","current":-10.442748,"twenty":-19.823144,"median":-9.089061,"eighty":-2.265217,"marketCap":1376782280},{"date":"2021-06-11","current":-11.476063,"twenty":-19.114288,"median":-9.089061,"eighty":-2.265217,"marketCap":1513015609},{"date":"2021-06-18","current":-9.941746,"twenty":-18.604721,"median":-9.089061,"eighty":-2.265217,"marketCap":1310729757},{"date":"2021-06-25","current":-10.677592,"twenty":-18.375305,"median":-9.089061,"eighty":-2.265217,"marketCap":1407744400},{"date":"2021-07-02","current":-10.05134,"twenty":-17.777501,"median":-9.089061,"eighty":-2.265217,"marketCap":1325178746},{"date":"2021-07-09","current":-9.50337,"twenty":-17.466467,"median":-9.089061,"eighty":-2.265217,"marketCap":1252933799},{"date":"2021-07-16","current":-8.767524,"twenty":-17.291765,"median":-9.033507,"eighty":-2.265217,"marketCap":1155919156},{"date":"2021-07-23","current":-8.470055,"twenty":-16.99447,"median":-8.971524,"eighty":-2.265217,"marketCap":1116700470},{"date":"2021-07-30","current":-8.595305,"twenty":-16.678803,"median":-8.916789,"eighty":-2.265217,"marketCap":1133213601},{"date":"2021-08-06","current":-8.704899,"twenty":-16.617652,"median":-8.830149,"eighty":-2.265217,"marketCap":1147662590},{"date":"2021-08-13","current":-11.689937,"twenty":-16.486199,"median":-8.830149,"eighty":-2.265217,"marketCap":1268790647},{"date":"2021-08-20","current":-10.699909,"twenty":-16.395145,"median":-8.830149,"eighty":-2.265217,"marketCap":1161336065},{"date":"2021-08-27","current":-11.423391,"twenty":-16.260851,"median":-8.830149,"eighty":-2.265217,"marketCap":1239860568},{"date":"2021-09-03","current":-11.689937,"twenty":-16.058109,"median":-8.830149,"eighty":-2.265217,"marketCap":1268790647},{"date":"2021-09-10","current":-11.766093,"twenty":-15.964337,"median":-8.830149,"eighty":-2.265217,"marketCap":1277056385},{"date":"2021-09-17","current":-10.433364,"twenty":-15.837453,"median":-8.830149,"eighty":-2.265217,"marketCap":1132405985},{"date":"2021-09-24","current":-10.071623,"twenty":-15.768639,"median":-8.830149,"eighty":-2.265217,"marketCap":1093143734},{"date":"2021-10-01","current":-9.728921,"twenty":-15.656957,"median":-8.830149,"eighty":-2.265217,"marketCap":1055947917},{"date":"2021-10-08","current":-8.891206,"twenty":-15.509068,"median":-8.830149,"eighty":-2.265217,"marketCap":965024808},{"date":"2021-10-15","current":-8.853128,"twenty":-15.43114,"median":-8.812374,"eighty":-2.265217,"marketCap":960891940},{"date":"2021-10-22","current":-8.738894,"twenty":-15.315024,"median":-8.78318,"eighty":-2.265217,"marketCap":948493334},{"date":"2021-10-29","current":-9.19583,"twenty":-15.216955,"median":-8.768171,"eighty":-2.265217,"marketCap":998087757},{"date":"2021-11-05","current":-9.728921,"twenty":-15.176108,"median":-8.768171,"eighty":-2.265217,"marketCap":1055947917},{"date":"2021-11-12","current":-8.228266,"twenty":-15.007591,"median":-8.748963,"eighty":-2.265217,"marketCap":895177700},{"date":"2021-11-19","current":-7.145099,"twenty":-14.86848,"median":-8.716954,"eighty":-2.265217,"marketCap":777336756},{"date":"2021-11-26","current":-7.335128,"twenty":-14.813632,"median":-8.704899,"eighty":-2.265217,"marketCap":798010606},{"date":"2021-12-03","current":-6.974073,"twenty":-14.700486,"median":-8.613591,"eighty":-2.265217,"marketCap":758730291},{"date":"2021-12-10","current":-7.316125,"twenty":-14.595651,"median":-8.548336,"eighty":-2.265217,"marketCap":795943221},{"date":"2021-12-17","current":-7.525157,"twenty":-14.509288,"median":-8.503337,"eighty":-2.265217,"marketCap":818684456},{"date":"2021-12-23","current":-7.791198,"twenty":-14.455704,"median":-8.478712,"eighty":-2.265217,"marketCap":847627845},{"date":"2021-12-31","current":-7.050084,"twenty":-14.176791,"median":-8.309862,"eighty":-2.265217,"marketCap":766999831},{"date":"2022-01-07","current":-6.023927,"twenty":-13.919719,"median":-8.23949,"eighty":-2.26523,"marketCap":655361041},{"date":"2022-01-14","current":-6.137944,"twenty":-13.839863,"median":-8.163687,"eighty":-2.26523,"marketCap":667765351},{"date":"2022-01-21","current":-5.339821,"twenty":-13.638588,"median":-8.019503,"eighty":-2.26523,"marketCap":580935182},{"date":"2022-01-28","current":-4.674719,"twenty":-13.431289,"median":-7.907969,"eighty":-2.26523,"marketCap":508576707},{"date":"2022-02-04","current":-4.256655,"twenty":-13.226283,"median":-7.572665,"eighty":-2.26523,"marketCap":463094237},{"date":"2022-02-11","current":-4.085628,"twenty":-13.118179,"median":-7.530036,"eighty":-2.26523,"marketCap":444487772},{"date":"2022-02-18","current":-3.876596,"twenty":-13.014792,"median":-7.468149,"eighty":-2.26523,"marketCap":421746537},{"date":"2022-02-25","current":-4.199646,"twenty":-12.960648,"median":-7.316125,"eighty":-2.26523,"marketCap":456892082},{"date":"2022-03-04","current":-4.53532,"twenty":-12.851835,"median":-7.203504,"eighty":-2.26523,"marketCap":418002320},{"date":"2022-03-11","current":-4.625129,"twenty":-12.734061,"median":-7.126096,"eighty":-2.26523,"marketCap":426279594},{"date":"2022-03-18","current":-4.939458,"twenty":-12.663626,"median":-7.094428,"eighty":-2.26523,"marketCap":455250052},{"date":"2022-03-25","current":-4.625129,"twenty":-12.545232,"median":-6.999388,"eighty":-2.26523,"marketCap":426279594},{"date":"2022-04-01","current":-5.096622,"twenty":-12.521555,"median":-6.903414,"eighty":-2.26523,"marketCap":469735281},{"date":"2022-04-08","current":-4.782293,"twenty":-12.418538,"median":-6.857508,"eighty":-2.26523,"marketCap":440764823},{"date":"2022-04-14","current":-3.99647,"twenty":-12.364913,"median":-6.774435,"eighty":-2.26523,"marketCap":368338678},{"date":"2022-04-22","current":-3.592333,"twenty":-12.32787,"median":-6.683553,"eighty":-2.26523,"marketCap":331090947},{"date":"2022-04-29","current":-2.997115,"twenty":-12.287207,"median":-6.568515,"eighty":-2.26523,"marketCap":276232058},{"date":"2022-05-06","current":-2.816837,"twenty":-12.223444,"median":-6.505484,"eighty":-2.26523,"marketCap":259616596},{"date":"2022-05-13","current":-2.979691,"twenty":-12.188367,"median":-6.436134,"eighty":-2.26523,"marketCap":280385923},{"date":"2022-05-20","current":-2.736901,"twenty":-12.060236,"median":-6.371056,"eighty":-2.26523,"marketCap":257539663},{"date":"2022-05-27","current":-3.045906,"twenty":-11.918711,"median":-6.322174,"eighty":-2.26523,"marketCap":286616722},{"date":"2022-06-03","current":-2.758973,"twenty":-11.901639,"median":-6.273291,"eighty":-2.26523,"marketCap":259616596},{"date":"2022-06-10","current":-2.957619,"twenty":-11.809736,"median":-6.237578,"eighty":-2.26523,"marketCap":278308991},{"date":"2022-06-17","current":-2.979691,"twenty":-11.75656,"median":-6.198545,"eighty":-2.26523,"marketCap":280385923},{"date":"2022-06-24","current":-3.09005,"twenty":-11.697553,"median":-6.166012,"eighty":-2.265217,"marketCap":290770587},{"date":"2022-07-01","current":-3.112121,"twenty":-11.663369,"median":-6.110348,"eighty":-2.265217,"marketCap":292847520},{"date":"2022-07-08","current":-3.575629,"twenty":-11.613097,"median":-6.061932,"eighty":-2.265217,"marketCap":336463108},{"date":"2022-07-15","current":-3.730131,"twenty":-11.577767,"median":-5.991795,"eighty":-2.265217,"marketCap":351001638},{"date":"2022-07-22","current":-4.039136,"twenty":-11.508377,"median":-5.923353,"eighty":-2.265217,"marketCap":380078696},{"date":"2022-07-29","current":-3.46527,"twenty":-11.441947,"median":-5.854911,"eighty":-2.265217,"marketCap":326078444},{"date":"2022-08-05","current":-4.568859,"twenty":-11.337169,"median":-5.820376,"eighty":-2.265217,"marketCap":429925083},{"date":"2022-08-12","current":-5.380607,"twenty":-11.228538,"median":-5.751839,"eighty":-2.265217,"marketCap":493315549},{"date":"2022-08-19","current":-4.858438,"twenty":-11.162847,"median":-5.696684,"eighty":-2.265217,"marketCap":445441044},{"date":"2022-08-26","current":-5.607637,"twenty":-11.122487,"median":-5.648582,"eighty":-2.265217,"marketCap":514130551},{"date":"2022-09-02","current":-5.40331,"twenty":-11.052235,"median":-5.548133,"eighty":-2.265217,"marketCap":495397049},{"date":"2022-09-09","current":-6.288726,"twenty":-11.016019,"median":-5.510848,"eighty":-2.265217,"marketCap":576575558},{"date":"2022-09-16","current":-6.175211,"twenty":-10.943123,"median":-5.510848,"eighty":-2.265217,"marketCap":566168057},{"date":"2022-09-23","current":-4.94925,"twenty":-10.852592,"median":-5.476788,"eighty":-2.265217,"marketCap":453767045},{"date":"2022-09-30","current":-4.813032,"twenty":-10.806439,"median":-5.388499,"eighty":-2.265217,"marketCap":441278044},{"date":"2022-10-07","current":-3.995725,"twenty":-10.707143,"median":-5.35715,"eighty":-2.265217,"marketCap":366344036},{"date":"2022-10-14","current":-3.904913,"twenty":-10.668198,"median":-5.319818,"eighty":-2.265217,"marketCap":358018036},{"date":"2022-10-21","current":-3.904913,"twenty":-10.648622,"median":-5.244389,"eighty":-2.265217,"marketCap":358018036},{"date":"2022-10-28","current":-3.65518,"twenty":-10.547819,"median":-5.226488,"eighty":-2.265217,"marketCap":335121533},{"date":"2022-11-04","current":-3.677883,"twenty":-10.487588,"median":-5.179203,"eighty":-2.265217,"marketCap":337203034},{"date":"2022-11-11","current":15.04364,"twenty":-10.473158,"median":-5.145602,"eighty":-2.246084,"marketCap":382996038},{"date":"2022-11-18","current":16.024747,"twenty":-10.473158,"median":-5.096622,"eighty":-2.229125,"marketCap":407974041},{"date":"2022-11-25","current":15.697712,"twenty":-10.473158,"median":-5.040062,"eighty":-2.219243,"marketCap":399648040},{"date":"2022-12-02","current":15.452435,"twenty":-10.473158,"median":-4.994739,"eighty":-2.167914,"marketCap":393403539},{"date":"2022-12-09","current":12.754391,"twenty":-10.473158,"median":-4.94076,"eighty":-2.131942,"marketCap":324714032},{"date":"2022-12-16","current":12.917909,"twenty":-10.473158,"median":-4.903844,"eighty":-2.090012,"marketCap":328877033},{"date":"2022-12-23","current":11.446248,"twenty":-10.473158,"median":-4.827197,"eighty":-2.075045,"marketCap":291410029},{"date":"2022-12-30","current":12.427355,"twenty":-10.473158,"median":-4.813032,"eighty":-2.057604,"marketCap":316388031},{"date":"2023-01-06","current":13.081426,"twenty":-10.443662,"median":-4.788989,"eighty":-2.037097,"marketCap":333040033},{"date":"2023-01-13","current":16.433542,"twenty":-10.377797,"median":-4.737389,"eighty":-2.008764,"marketCap":418381542},{"date":"2023-01-20","current":16.270024,"twenty":-10.342153,"median":-4.679218,"eighty":-1.996066,"marketCap":414218541},{"date":"2023-01-27","current":16.169203,"twenty":-10.283105,"median":-4.655716,"eighty":-1.969698,"marketCap":411651748},{"date":"2023-02-03","current":18.042465,"twenty":-10.23838,"median":-4.625129,"eighty":-1.957173,"marketCap":459343110},{"date":"2023-02-10","current":16.563574,"twenty":-10.182491,"median":-4.602676,"eighty":-1.943793,"marketCap":421692035},{"date":"2023-02-17","current":13.704386,"twenty":-10.068847,"median":-4.580224,"eighty":-1.934623,"marketCap":348899957},{"date":"2023-02-24","current":11.831124,"twenty":-9.980244,"median":-4.53532,"eighty":-1.916437,"marketCap":301208596},{"date":"2023-03-03","current":11.436754,"twenty":-9.906706,"median":-4.457236,"eighty":-1.911874,"marketCap":291168310},{"date":"2023-03-10","current":9.707675,"twenty":-9.87776,"median":-4.391808,"eighty":-1.895398,"marketCap":274892237},{"date":"2023-03-17","current":9.084246,"twenty":-9.807102,"median":-4.333251,"eighty":-1.884496,"marketCap":257238607},{"date":"2023-03-24","current":8.55077,"twenty":-9.731994,"median":-4.277311,"eighty":-1.873943,"marketCap":242132143},{"date":"2023-03-31","current":9.440491,"twenty":-9.680634,"median":-4.230204,"eighty":-1.862004,"marketCap":267326395},{"date":"2023-04-06","current":8.712861,"twenty":-9.560826,"median":-4.207679,"eighty":-1.852795,"marketCap":246722087},{"date":"2023-04-14","current":9.885798,"twenty":-9.448255,"median":-4.177349,"eighty":-1.849063,"marketCap":279936131},{"date":"2023-04-21","current":10.331104,"twenty":-9.381662,"median":-4.138277,"eighty":-1.836619,"marketCap":292545867},{"date":"2023-04-28","current":10.55602,"twenty":-9.220442,"median":-4.10924,"eighty":-1.825677,"marketCap":298914821},{"date":"2023-05-05","current":10.826687,"twenty":-9.052743,"median":-4.081029,"eighty":-1.805941,"marketCap":306579303},{"date":"2023-05-12","current":11.727887,"twenty":-8.972531,"median":-3.996098,"eighty":-1.802363,"marketCap":291250338},{"date":"2023-05-19","current":12.859525,"twenty":-8.891206,"median":-3.950849,"eighty":-1.78949,"marketCap":319353441},{"date":"2023-05-26","current":12.345144,"twenty":-8.872002,"median":-3.904913,"eighty":-1.770557,"marketCap":306579303},{"date":"2023-06-01","current":12.242268,"twenty":-8.825303,"median":-3.887568,"eighty":-1.756116,"marketCap":304024476},{"date":"2023-06-16","current":13.065277,"twenty":-8.720415,"median":-3.828559,"eighty":-1.728731,"marketCap":324463096},{"date":"2023-06-22","current":12.036515,"twenty":-8.700816,"median":-3.782982,"eighty":-1.724142,"marketCap":298914821},{"date":"2023-06-27","current":10.802001,"twenty":-8.610961,"median":-3.760449,"eighty":-1.717307,"marketCap":268256890},{"date":"2023-07-07","current":11.110629,"twenty":-8.534192,"median":-3.723289,"eighty":-1.711177,"marketCap":275921373},{"date":"2023-07-14","current":12.139391,"twenty":-8.462138,"median":-3.687433,"eighty":-1.690087,"marketCap":301469648},{"date":"2023-07-21","current":13.888287,"twenty":-8.275719,"median":-3.671045,"eighty":-1.673949,"marketCap":344901716},{"date":"2023-07-28","current":12.859525,"twenty":-8.175987,"median":-3.621879,"eighty":-1.653439,"marketCap":319353441},{"date":"2023-08-04","current":11.522134,"twenty":-7.882412,"median":-3.596322,"eighty":-1.629485,"marketCap":286140683},{"date":"2023-08-11","current":17.531999,"twenty":-7.559362,"median":-3.569881,"eighty":-1.606251,"marketCap":388333784},{"date":"2023-08-18","current":19.838841,"twenty":-7.517556,"median":-3.531485,"eighty":-1.571461,"marketCap":439430335},{"date":"2023-08-25","current":17.647341,"twenty":-7.41114,"median":-3.421126,"eighty":-1.54177,"marketCap":390888612},{"date":"2023-09-01","current":20.184868,"twenty":-7.236313,"median":-3.385863,"eighty":-1.516081,"marketCap":447094817},{"date":"2023-09-08","current":18.570078,"twenty":-7.179304,"median":-3.322908,"eighty":-1.506974,"marketCap":411327232},{"date":"2023-09-15","current":17.01296,"twenty":-7.119961,"median":-3.255552,"eighty":-1.480727,"marketCap":376837060},{"date":"2023-09-22","current":16.147894,"twenty":-7.057356,"median":-3.165982,"eighty":-1.449285,"marketCap":357675854},{"date":"2023-09-29","current":16.378578,"twenty":-6.974073,"median":-3.109788,"eighty":-1.437628,"marketCap":362785509},{"date":"2023-10-06","current":15.801868,"twenty":-6.896259,"median":-3.067978,"eighty":-1.43179,"marketCap":350011371},{"date":"2023-10-13","current":13.495026,"twenty":-6.842051,"median":-2.997115,"eighty":-1.386334,"marketCap":298914821},{"date":"2023-10-20","current":12.341605,"twenty":-6.712195,"median":-2.978804,"eighty":-1.348887,"marketCap":273366545},{"date":"2023-10-27","current":12.802973,"twenty":-6.637618,"median":-2.957619,"eighty":-1.339825,"marketCap":283585855},{"date":"2023-11-03","current":12.802973,"twenty":-6.550293,"median":-2.932529,"eighty":-1.318161,"marketCap":283585855},{"date":"2023-11-10","current":-3.786087,"twenty":-6.464548,"median":-2.869332,"eighty":-1.259758,"marketCap":321908268},{"date":"2023-11-17","current":-3.366778,"twenty":-6.398757,"median":-2.858296,"eighty":-1.259758,"marketCap":286256960},{"date":"2023-11-24","current":-3.396055,"twenty":-6.356292,"median":-2.858296,"eighty":-1.259758,"marketCap":288746151},{"date":"2023-12-01","current":-3.278949,"twenty":-6.322174,"median":-2.858296,"eighty":-1.259758,"marketCap":278789387},{"date":"2023-12-08","current":-3.425331,"twenty":-6.274412,"median":-2.869332,"eighty":-1.261195,"marketCap":291235342},{"date":"2023-12-15","current":-3.688818,"twenty":-6.273291,"median":-2.869332,"eighty":-1.261195,"marketCap":313638060},{"date":"2023-12-22","current":-3.308226,"twenty":-6.273291,"median":-2.869332,"eighty":-1.261195,"marketCap":281278578},{"date":"2023-12-29","current":-4.127963,"twenty":-6.273291,"median":-2.858296,"eighty":-1.259758,"marketCap":350975925},{"date":"2024-01-05","current":-3.8352,"twenty":-6.273291,"median":-2.84726,"eighty":-1.258322,"marketCap":326084015},{"date":"2024-01-12","current":-4.040134,"twenty":-6.262832,"median":-2.84726,"eighty":-1.258322,"marketCap":343508352},{"date":"2024-01-19","current":-3.542436,"twenty":-6.209724,"median":-2.84726,"eighty":-1.256885,"marketCap":301192106},{"date":"2024-01-26","current":-4.157239,"twenty":-6.17578,"median":-2.84726,"eighty":-1.258322,"marketCap":353465116},{"date":"2024-02-02","current":-4.098687,"twenty":-6.16061,"median":-2.84726,"eighty":-1.258322,"marketCap":348486734},{"date":"2024-02-09","current":-4.054772,"twenty":-6.099968,"median":-2.84726,"eighty":-1.258322,"marketCap":344752943},{"date":"2024-02-16","current":-4.186516,"twenty":-6.038779,"median":-2.84726,"eighty":-1.258322,"marketCap":355954302},{"date":"2024-02-23","current":-4.215792,"twenty":-5.978426,"median":-2.84726,"eighty":-1.258322,"marketCap":358443493},{"date":"2024-03-01","current":-4.508555,"twenty":-5.925577,"median":-2.858296,"eighty":-1.259758,"marketCap":383335403},{"date":"2024-03-08","current":-4.889148,"twenty":-5.925577,"median":-2.858296,"eighty":-1.259758,"marketCap":415694885},{"date":"2024-03-15","current":-4.186516,"twenty":-5.925577,"median":-2.858296,"eighty":-1.259758,"marketCap":355954302},{"date":"2024-03-22","current":-3.971119,"twenty":-5.925577,"median":-2.858296,"eighty":-1.259758,"marketCap":380846216},{"date":"2024-03-28","current":-3.763479,"twenty":-5.925577,"median":-2.858296,"eighty":-1.259758,"marketCap":360932689},{"date":"2024-04-05","current":-3.529884,"twenty":-5.926688,"median":-2.84726,"eighty":-1.258322,"marketCap":338529970},{"date":"2024-04-12","current":-3.763479,"twenty":-5.926688,"median":-2.84726,"eighty":-1.258322,"marketCap":360932689},{"date":"2024-04-19","current":-3.426064,"twenty":-5.926688,"median":-2.84726,"eighty":-1.258322,"marketCap":328573206},{"date":"2024-04-26","current":-3.633704,"twenty":-5.925577,"median":-2.858296,"eighty":-1.259758,"marketCap":348486734},{"date":"2024-05-03","current":-3.633704,"twenty":-5.925577,"median":-2.858296,"eighty":-1.259758,"marketCap":348486734},{"date":"2024-05-10","current":-3.395285,"twenty":-5.925577,"median":-2.869332,"eighty":-1.259758,"marketCap":325621400},{"date":"2024-05-17","current":-3.646629,"twenty":-5.925577,"median":-2.935784,"eighty":-1.259758,"marketCap":353387566},{"date":"2024-05-24","current":-3.490345,"twenty":-5.925577,"median":-2.957619,"eighty":-1.259758,"marketCap":338242384},{"date":"2024-05-31","current":-3.646629,"twenty":-5.925577,"median":-2.979247,"eighty":-1.259758,"marketCap":353387566},{"date":"2024-06-07","current":-4.219671,"twenty":-5.925577,"median":-2.999439,"eighty":-1.259758,"marketCap":408919897},{"date":"2024-06-14","current":-4.245719,"twenty":-5.925577,"median":-3.068849,"eighty":-1.259758,"marketCap":411444094},{"date":"2024-06-21","current":-4.011292,"twenty":-5.926688,"median":-3.103291,"eighty":-1.258322,"marketCap":388726322},{"date":"2024-06-28","current":-4.115482,"twenty":-5.926688,"median":-3.154857,"eighty":-1.258322,"marketCap":398823110},{"date":"2024-07-05","current":-3.698724,"twenty":-5.926688,"median":-3.19112,"eighty":-1.258322,"marketCap":358435959},{"date":"2024-07-12","current":-4.193624,"twenty":-5.926688,"median":-3.235505,"eighty":-1.258322,"marketCap":406395700},{"date":"2024-07-19","current":-4.141529,"twenty":-5.926688,"median":-3.278949,"eighty":-1.258322,"marketCap":401347307},{"date":"2024-07-26","current":-4.375955,"twenty":-5.926688,"median":-3.31305,"eighty":-1.258322,"marketCap":424065079},{"date":"2024-08-02","current":-3.594535,"twenty":-5.926688,"median":-3.366778,"eighty":-1.258322,"marketCap":348339172},{"date":"2024-08-09","current":-3.265831,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":316485188},{"date":"2024-08-16","current":-2.319249,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":313982305},{"date":"2024-08-23","current":-2.468192,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":334146306},{"date":"2024-08-30","current":-2.340527,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":316862877},{"date":"2024-09-06","current":-2.000087,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":270773731},{"date":"2024-09-13","current":-2.234139,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":302460019},{"date":"2024-09-20","current":-2.117113,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":286616875},{"date":"2024-09-27","current":-2.013917,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":272646102},{"date":"2024-10-04","current":-1.914977,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":259251444},{"date":"2024-10-11","current":-1.911998,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":258848164},{"date":"2024-10-18","current":-2.02796,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":274547280},{"date":"2024-10-25","current":-1.808589,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":244848586},{"date":"2024-11-01","current":-1.737948,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":235285089},{"date":"2024-11-08","current":-2.07626,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":281086177},{"date":"2024-11-15","current":-1.720945,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":240181946},{"date":"2024-11-22","current":-1.894068,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":264343646},{"date":"2024-11-29","current":-1.955972,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":272983285},{"date":"2024-12-06","current":-1.629662,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":227442140},{"date":"2024-12-13","current":-1.417088,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":197774501},{"date":"2024-12-20","current":-1.600284,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":223341973},{"date":"2024-12-27","current":-1.52411,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":212710825},{"date":"2025-01-03","current":-2.518149,"twenty":-5.926688,"median":-3.386156,"eighty":-1.258322,"marketCap":351442916},{"date":"2025-01-10","current":-2.465687,"twenty":-5.9278,"median":-3.390721,"eighty":-1.256885,"marketCap":344121188},{"date":"2025-01-17","current":-2.329288,"twenty":-5.9278,"median":-3.390721,"eighty":-1.256885,"marketCap":325084697},{"date":"2025-01-24","current":-2.916856,"twenty":-5.9278,"median":-3.390721,"eighty":-1.256885,"marketCap":407088044},{"date":"2025-01-31","current":-2.832917,"twenty":-5.9278,"median":-3.390721,"eighty":-1.256885,"marketCap":395373280},{"date":"2025-02-07","current":-3.567377,"twenty":-5.9278,"median":-3.39567,"eighty":-1.256885,"marketCap":497877464},{"date":"2025-02-14","current":-4.112976,"twenty":-5.9278,"median":-3.399582,"eighty":-1.256885,"marketCap":574023430},{"date":"2025-02-21","current":-4.008053,"twenty":-5.9278,"median":-3.423229,"eighty":-1.256885,"marketCap":559379975},{"date":"2025-02-28","current":-3.630331,"twenty":-5.9278,"median":-3.453313,"eighty":-1.256885,"marketCap":506663537},{"date":"2025-03-07","current":-3.903131,"twenty":-5.928912,"median":-3.490345,"eighty":-1.255448,"marketCap":544736520},{"date":"2025-03-14","current":-3.777223,"twenty":-5.928912,"median":-3.529884,"eighty":-1.34609,"marketCap":527164374},{"date":"2025-03-21","current":-4.216087,"twenty":-5.928912,"median":-3.553205,"eighty":-1.373012,"marketCap":532217781},{"date":"2025-03-28","current":-3.703635,"twenty":-5.928912,"median":-3.567377,"eighty":-1.38378,"marketCap":467528327},{"date":"2025-04-04","current":-2.888369,"twenty":-5.928912,"median":-3.567377,"eighty":-1.38378,"marketCap":364613286},{"date":"2025-04-11","current":-3.261062,"twenty":-5.9278,"median":-3.567377,"eighty":-1.387011,"marketCap":411660162},{"date":"2025-04-17","current":-3.237769,"twenty":-5.9278,"median":-3.567377,"eighty":-1.387011,"marketCap":408719732},{"date":"2025-04-25","current":-3.493995,"twenty":-5.928912,"median":-3.569881,"eighty":-1.38378,"marketCap":441064459},{"date":"2025-05-02","current":-3.657048,"twenty":-5.928912,"median":-3.571713,"eighty":-1.38378,"marketCap":461647467},{"date":"2025-05-09","current":-3.098009,"twenty":-5.928912,"median":-3.571713,"eighty":-1.38378,"marketCap":391077154},{"date":"2025-05-16","current":-2.732276,"twenty":-5.928912,"median":-3.571713,"eighty":-1.413521,"marketCap":428011087},{"date":"2025-05-23","current":-2.619217,"twenty":-5.928912,"median":-3.571713,"eighty":-1.52306,"marketCap":410300283},{"date":"2025-05-30","current":-2.619217,"twenty":-5.928912,"median":-3.571713,"eighty":-1.574263,"marketCap":410300283},{"date":"2025-06-06","current":-2.506157,"twenty":-5.928912,"median":-3.571713,"eighty":-1.600284,"marketCap":392589479},{"date":"2025-06-13","current":-2.864179,"twenty":-5.928912,"median":-3.571713,"eighty":-1.600284,"marketCap":448673691},{"date":"2025-06-20","current":-2.807649,"twenty":-5.932766,"median":-3.573671,"eighty":-1.59508,"marketCap":439818289},{"date":"2025-06-27","current":-2.69459,"twenty":-5.932766,"median":-3.573671,"eighty":-1.59508,"marketCap":422107485},{"date":"2025-07-03","current":-3.052612,"twenty":-5.932766,"median":-3.573671,"eighty":-1.59508,"marketCap":478191697},{"date":"2025-07-11","current":-3.599067,"twenty":-5.932766,"median":-3.577927,"eighty":-1.59508,"marketCap":563793914},{"date":"2025-07-18","current":-3.429478,"twenty":-5.932766,"median":-3.581009,"eighty":-1.59508,"marketCap":537227709},{"date":"2025-07-25","current":-3.014926,"twenty":-5.932766,"median":-3.581009,"eighty":-1.59508,"marketCap":472288096},{"date":"2025-08-01","current":-3.222202,"twenty":-5.932766,"median":-3.581009,"eighty":-1.59508,"marketCap":504757902},{"date":"2025-08-08","current":-3.542538,"twenty":-5.932766,"median":-3.584481,"eighty":-1.59508,"marketCap":554938512},{"date":"2025-08-15","current":-4.42771,"twenty":-5.932766,"median":-3.594535,"eighty":-1.59508,"marketCap":551249902},{"date":"2025-08-22","current":-8.711819,"twenty":-5.992153,"median":-3.608761,"eighty":-1.59508,"marketCap":1084621428},{"date":"2025-08-29","current":-10.889773,"twenty":-6.065846,"median":-3.620582,"eighty":-1.59508,"marketCap":1355776786},{"date":"2025-09-05","current":-10.913707,"twenty":-6.15791,"median":-3.632165,"eighty":-1.589876,"marketCap":1358756515},{"date":"2025-09-12","current":-9.908497,"twenty":-6.19728,"median":-3.633704,"eighty":-1.59508,"marketCap":1233607888},{"date":"2025-09-19","current":-9.094756,"twenty":-6.260697,"median":-3.633704,"eighty":-1.59508,"marketCap":1132297096},{"date":"2025-09-26","current":-8.340848,"twenty":-6.408212,"median":-3.646655,"eighty":-1.59508,"marketCap":1038435626},{"date":"2025-10-03","current":-7.969878,"twenty":-6.830093,"median":-3.658354,"eighty":-1.59508,"marketCap":992249823},{"date":"2025-10-10","current":-7.634808,"twenty":-7.032159,"median":-3.665995,"eighty":-1.59508,"marketCap":950533614},{"date":"2025-10-17","current":-8.352815,"twenty":-7.126096,"median":-3.677883,"eighty":-1.59508,"marketCap":1039925490},{"date":"2025-10-24","current":-10.171766,"twenty":-7.224912,"median":-3.688818,"eighty":-1.59508,"marketCap":1266384910},{"date":"2025-10-31","current":-9.693095,"twenty":-7.354131,"median":-3.703635,"eighty":-1.59508,"marketCap":1206790326},{"date":"2025-11-07","current":-9.381959,"twenty":-7.487152,"median":-3.72403,"eighty":-1.59508,"marketCap":1168053846},{"date":"2025-11-14","current":-10.96998,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1365762566},{"date":"2025-11-21","current":-5.589735,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1379915546},{"date":"2025-11-28","current":-5.489407,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1355147831},{"date":"2025-12-05","current":-5.374745,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1326841871},{"date":"2025-12-12","current":-5.188421,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1280844686},{"date":"2025-12-19","current":-5.976717,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1475448160},{"date":"2025-12-26","current":-6.005382,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1482524650},{"date":"2026-01-02","current":-5.991049,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1478986405},{"date":"2026-01-09","current":-6.607354,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1631130940},{"date":"2026-01-16","current":-5.933719,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1464833425},{"date":"2026-01-23","current":-6.937005,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1712510575},{"date":"2026-01-30","current":-6.492692,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1602824980},{"date":"2026-02-06","current":-6.077045,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1500215875},{"date":"2026-02-13","current":-6.793678,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1677128125},{"date":"2026-02-20","current":-6.464027,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1595748490},{"date":"2026-02-27","current":-5.460741,"twenty":-7.54416,"median":-3.735254,"eighty":-1.59508,"marketCap":1348071341},{"date":"2026-03-06","current":-4.830104,"twenty":-7.487152,"median":-3.735254,"eighty":-1.59508,"marketCap":1192388561},{"date":"2026-03-13","current":-4.701111,"twenty":-7.437569,"median":-3.735254,"eighty":-1.59508,"marketCap":1160544356},{"date":"2026-03-20","current":-4.758441,"twenty":-7.243915,"median":-3.735254,"eighty":-1.59508,"marketCap":1174697336},{"date":"2026-03-27","current":-5.493024,"twenty":-7.129897,"median":-3.735254,"eighty":-1.59508,"marketCap":1376782534},{"date":"2026-04-02","current":-5.549508,"twenty":-7.061522,"median":-3.735254,"eighty":-1.59508,"marketCap":1390939680},{"date":"2026-04-10","current":-6.029618,"twenty":-7.024617,"median":-3.735254,"eighty":-1.59508,"marketCap":1511275429}],"updateTime":1776032671791},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PGEN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583949155","title":"AquaBounty Technologies Inc. Files Initial Beneficial Ownership Statement for Director Braeden Lichti","url":"https://stock-news.laohu8.com/highlight/detail?id=2583949155","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583949155?lang=en_us&edition=fundamental","pubTime":"2025-11-13 23:33","pubTimestamp":1763048029,"startTime":"0","endTime":"0","summary":"AquaBounty Technologies Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Braeden Lichti as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AquaBounty Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL47Fwwc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGEN","AQB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581045373","title":"Precigen Inc. to Report Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581045373","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581045373?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:42","pubTimestamp":1762465335,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precigen Inc. published the original content used to generate this news brief via PR Newswire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL1yhZJz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580231363","title":"Will Papzimeos FDA Approval and Major Buy Shift Precigen's (PGEN) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2580231363","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580231363?lang=en_us&edition=fundamental","pubTime":"2025-11-03 02:29","pubTimestamp":1762108192,"startTime":"0","endTime":"0","summary":"During the third quarter of 2025, Precigen received full FDA approval for Papzimeos, the only approved treatment for recurrent respiratory papillomatosis, and saw Patient Capital Management purchase 10.2 million shares in the company.\nThis dual milestone highlights both clinical progress in gene and cell therapy and increasing institutional confidence in Precigen's therapeutic platforms.\nWe'll take a closer look at how the FDA approval of Papzimeos helps shape Precigen's investment...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/will-papzimeos-fda-approval-and-major-buy-shift-precigens-pg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/will-papzimeos-fda-approval-and-major-buy-shift-precigens-pg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579173990","title":"AquaBounty Technologies Secures $4 Million in Senior Notes Financing at 18% Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2579173990","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579173990?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:17","pubTimestamp":1761686267,"startTime":"0","endTime":"0","summary":"AquaBounty Technologies Inc. has entered into new Note Purchase Agreements with certain investors, resulting in the issuance and sale of $4 million in Senior Notes through a private placement. The Senior Notes are unsecured, nonconvertible, and bear interest at 18% per annum, with a scheduled maturity date of 18 months from closing. Principal and interest are payable at maturity, or earlier if accelerated due to an event of default. Proceeds from the financing will be used for general corporate purposes, including working capital, operational funding, and debt repayment. Univest Securities, LLC acted as placement agent and will receive a fee equal to 7% of the gross proceeds, plus up to $125,000 for expenses. The agreements include restrictive covenants and allow investors to nominate an additional director to the board in the event of default.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL5njgsv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGEN","BK4139","AQB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578345959","title":"AquaBounty Technologies Reports $1.4 Million Net Loss for Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2578345959","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578345959?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:03","pubTimestamp":1761652989,"startTime":"0","endTime":"0","summary":"AquaBounty Technologies Inc. reported a net loss of $1.4 million for the third quarter ended September 30, 2025, compared to a net loss of $3.4 million for the same period in 2024. The results for the current quarter included a non-cash asset impairment charge of $69 thousand related to equipment for the Ohio Farm Project. Cash and cash equivalents totaled $951 thousand as of September 30, 2025, up from $230 thousand as of December 31, 2024. The company's Ohio Farm project has received both its wastewater discharge permit from the Ohio Environmental Protection Agency and the necessary right-of-way permit for water lines from Williams County, enabling the project to proceed as planned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aqua","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL879SGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AQB","BK4139","PGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578600789","title":"A Look at Precigen's (PGEN) Valuation Following FDA Approval of PAPZIMEOS","url":"https://stock-news.laohu8.com/highlight/detail?id=2578600789","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578600789?lang=en_us&edition=fundamental","pubTime":"2025-10-28 09:24","pubTimestamp":1761614696,"startTime":"0","endTime":"0","summary":"Precigen (PGEN) has drawn attention after the FDA granted full approval to PAPZIMEOS, its immunotherapy for adults with recurrent respiratory papillomatosis. The therapy's pivotal study showed a meaningful patient response and set a new benchmark in the field.\nSee our latest analysis for Precigen.\nAfter a challenging few years, Precigen’s fortunes have quickly turned. Share price momentum has exploded since January, driven by catalysts like the PAPZIMEOS approval and positive trial updates...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/a-look-at-precigens-pgen-valuation-following-fda-approval-of","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/a-look-at-precigens-pgen-valuation-following-fda-approval-of","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578967302","title":"Precigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2578967302","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578967302?lang=en_us&edition=fundamental","pubTime":"2025-10-28 04:16","pubTimestamp":1761596160,"startTime":"0","endTime":"0","summary":"Precigen, Inc. (($PGEN)) announced an update on their ongoing clinical study. Precigen, Inc. is conducting a Phase 2 clinical study titled ‘A Rando...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/precigens-promising-phase-2-study-prgn-2009-and-pembrolizumab-for-cervical-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/precigens-promising-phase-2-study-prgn-2009-and-pembrolizumab-for-cervical-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2576994310","title":"A Look at Precigen (PGEN) Valuation After PAPZIMEOS’ Full FDA Approval and Clinical Breakthroughs","url":"https://stock-news.laohu8.com/highlight/detail?id=2576994310","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576994310?lang=en_us&edition=fundamental","pubTime":"2025-10-18 10:22","pubTimestamp":1760754166,"startTime":"0","endTime":"0","summary":"Precigen (PGEN) is in the spotlight after sharing long-term follow-up data on PAPZIMEOS, its gene therapy for recurrent respiratory papillomatosis, and confirming full FDA approval in August. These milestones set a new benchmark for treatment options.\nSee our latest analysis for Precigen.\nAfter announcing robust follow-up results for PAPZIMEOS and securing full FDA approval in August, Precigen’s share price return has soared, up 270% year-to-date and an incredible 127% over the past three...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/a-look-at-precigen-pgen-valuation-after-papzimeos-full-fda-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pgen/precigen/news/a-look-at-precigen-pgen-valuation-after-papzimeos-full-fda-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","PGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575281804","title":"BUZZ-U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv","url":"https://stock-news.laohu8.com/highlight/detail?id=2575281804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575281804?lang=en_us&edition=fundamental","pubTime":"2025-10-14 01:46","pubTimestamp":1760377569,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, VertivEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nL6N3VU0HC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGT","BK4566","LU0878866978.SGD","XOM","STX","SRRK","STUB","CVX","RNA","SG9999014542.SGD","SCCO","NDRA","FAST","NPO","MKSI","NEM","ALK","KDP","COP","LU0496367417.USD","LU2054465674.USD","PGEN","LU1571399168.USD","BK4567","MACW.SI","VRT","ABEO","BCAX","BK4500","TVRD","DVN","BK4155","ARDX","JEF","CERO","LNT","AGX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2575017244","title":"Sector Update: Health Care Stocks Higher Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2575017244","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575017244?lang=en_us&edition=fundamental","pubTime":"2025-10-13 21:20","pubTimestamp":1760361604,"startTime":"0","endTime":"0","summary":"Health care stocks were higher premarket Monday, with the Health Care Select Sector SPDR Fund  edging 0.03% higher and the iShares Biotechnology ETF  up 0.3%.Arcus Biosciences  stock was up nearly 9% after the company said a phase 2 study on various combinations of domvanalimab plus zimberelimab with chemotherapy achieved a 26.7-month median overall survival in patients with advanced stomach and esophageal cancer, including tumors not removable by surgery, with a 50% two-year survival rate.Precigen  shares were up nearly 6% after the company said follow-up data from a clinical study showed durable outcomes in 83% of adult recurrent respiratory papillomatosis patients treated with its drug Papzimeos.Tvardi Therapeutics  shares were down more than 85% after the company said a phase 2 clinical trial of its drug TTI-101 as a potential treatment for idiopathic pulmonary fibrosis failed to meet its goals.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RCUS","XLV","IBB","BK4007","TVRD","BK4581","XBI","LABU","PGEN","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575334405","title":"Precigen Shares Rise on Positive Long-Term Follow-Up Data From Papzimeos","url":"https://stock-news.laohu8.com/highlight/detail?id=2575334405","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575334405?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:54","pubTimestamp":1760356440,"startTime":"0","endTime":"0","summary":"Precigen shares were up 6%, to $3.32, in premarket trading after the company said it saw positive long-term follow-up data for Papzimeos for treatment of adults with recurrent respiratory papillomatosis.Papzimeos was granted full approval by the Food and Drug Administration in August.The biopharmaceutical company said Papzimeos approval was supported by results from a study that met its primary safety and pre-specified primary efficacy endpoints. Papzimeos was well tolerated with no dose-limiting toxicities and no treatment-related adverse events greater than Grade 2.The Germantown, Md., company said 51%, or 18 out of 35, of study patients achieved complete response, requiring no surgeries in the 12-month period after treatment with Papzimeos.Precigen said prolonged reduction in the requirement for surgical intervention to manage RRP was observed throughout long-term follow-up of evaluable study patients compared to the year prior to treatment.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575403005","title":"BUZZ-Precigen rises on long-term data of rare respiratory disease therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2575403005","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575403005?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:50","pubTimestamp":1760356247,"startTime":"0","endTime":"0","summary":"BUZZ-Precigen rises on long-term data of rare respiratory disease therapy** U.S. biotech firm Precigen's PGEN.O shares rise 5.5% to $3.29 premarket ** Co says its drug Papzimeos showed durable response in adults with recurrent respiratory papillomatosis , a rare respiratory disease that causes benign tumor growth in the airways** Durable response means patients stayed symptom-free without needing repeat surgeries for years** PGEN says 83% of patients with complete response to Papzimeos stayed surgery-free after 3 years** Co says 95% of patients needed fewer surgeries in year 3 compared to the year before starting Papzimeos ** In August, Papzimeos became the first FDA-approved therapy for adults with RRP ** Up to last close, stock up ~179% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nL3N3VU0PE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575587408","title":"BRIEF-Precigen Reports Durable Responses With Papzimeos in Recurrent Respiratory Papillomatosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2575587408","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575587408?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:11","pubTimestamp":1760353880,"startTime":"0","endTime":"0","summary":"BRIEF-Precigen Reports Durable Responses With Papzimeos in Recurrent Respiratory PapillomatosisOct 13 (Reuters) - Precigen Inc PGEN.O:PRECIGEN ANNOUNCES LONG-TERM FOLLOW-UP RESULTS HIGHLIGHTING ONGOIN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nTUA5ZRPSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575707894","title":"Precigen’s PAPZIMEOS Receives Full FDA Approval as First Therapy for Adults with Recurrent Respiratory Papillomatosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2575707894","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575707894?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:01","pubTimestamp":1760353293,"startTime":"0","endTime":"0","summary":"Precigen Inc. has announced that PAPZIMEOS  received full approval from the United States Food and Drug Administration  in August 2025 for the treatment of adults with recurrent respiratory papillomatosis . This marks PAPZIMEOS as the first and only FDA-approved therapy for adults with RRP. The approval was supported by pivotal study results demonstrating durable responses and a significant reduction in the need for surgeries among treated patients. No new safety events were observed during long-term follow-up. There is no indication that this approval or related funding involved multiple organizations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precigen Inc. published the original content used to generate this news brief via PR Ne","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDLc6lSWN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575702144","title":"Precigen Inc - Surgery Reduction Observed in 95% of Patients by Year 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2575702144","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575702144?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:00","pubTimestamp":1760353246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nTUA5ZRPSP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575470429","title":"Precigen Inc - 83% of Responders Show Continued Complete Response After 36 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2575470429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575470429?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:00","pubTimestamp":1760353246,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nTUA5ZRPSP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575470212","title":"Precigen Inc - No New Safety Events Observed During Long-Term Follow-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2575470212","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575470212?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:00","pubTimestamp":1760353246,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nTUA5ZRPSP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575423470","title":"Precigen Announces Long-Term Follow-up Results Highlighting Ongoing Durable Complete Responses After Treatment With Papzimeos, the First and Only FDA-Approved Therapy for Adults With Recurrent Respiratory Papillomatosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2575423470","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575423470?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:00","pubTimestamp":1760353246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nTUA5ZRPSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":58,"code":"91000000","status":"200"}]}}